Multimodality imaging of hypertrophic cardiomyopathy.

[1]  L. Axel,et al.  Apical Aneurysms and Mid-Left Ventricular Obstruction in Hypertrophic Cardiomyopathy. , 2023, JACC. Cardiovascular imaging.

[2]  James A. White,et al.  3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry. , 2022, JACC. Cardiovascular imaging.

[3]  N. Smedira,et al.  Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy. , 2022, Journal of the American College of Cardiology.

[4]  R. Chan,et al.  Clinical Characteristics and Prognostic Importance of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy. , 2022, JACC. Cardiovascular imaging.

[5]  M. Desai,et al.  Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Card , 2022, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  Matthew W. Martinez,et al.  2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[7]  D. Pennell,et al.  SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance , 2020, Journal of Cardiovascular Magnetic Resonance.

[8]  S. Solomon,et al.  Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial , 2020, The Lancet.

[9]  M. Desai,et al.  LV Global Function Index Provides Incremental Prognostic Value Over LGE and LV GLS in HCM. , 2020, JACC. Cardiovascular imaging.

[10]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.

[11]  M. Desai,et al.  Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature. , 2019, JACC. Cardiovascular imaging.

[12]  Narjes Benameur,et al.  Comparison Between 3D Echocardiography and Cardiac Magnetic Resonance Imaging (CMRI) in the Measurement of Left Ventricular Volumes and Ejection Fraction. , 2019, Current medical imaging reviews.

[13]  S. Colan,et al.  Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking. , 2019, Radiology.

[14]  N. Smedira,et al.  Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function. , 2018, Journal of the American College of Cardiology.

[15]  L. Zakhama,et al.  Accessory and solitary main papillary muscle hypertrophy resulting in dynamic mid-left ventricular obstruction: Contribution of multimodality imaging in highlighting of dynamic and structural abnormalities. , 2018, Journal of cardiology cases.

[16]  T. McDonagh,et al.  6 Comparing echocardiography and cardiac magnetic resonance measures of ejection fraction: implications for HFMRF research , 2018 .

[17]  Stefan L. Zimmerman,et al.  Rest and Stress Longitudinal Systolic Left Ventricular Mechanics in Hypertrophic Cardiomyopathy: Implications for Prognostication , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  S. Petersen,et al.  Doppler echocardiography underestimates the prevalence and magnitude of mid‐cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  M. Sherrid,et al.  Intraoperative Two‐ and Three‐Dimensional Transesophageal Echocardiography in Combined Myectomy‐Mitral Operations for Hypertrophic Cardiomyopathy , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  B. Maron,et al.  How to Image Hypertrophic Cardiomyopathy. , 2017, Circulation. Cardiovascular imaging.

[21]  S. Ommen,et al.  Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography. , 2017, The American journal of cardiology.

[22]  R. Chan,et al.  Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.

[23]  Jeffrey J Silbiger,et al.  Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  M. Maron,et al.  Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States. , 2016, The American journal of cardiology.

[25]  L. Axel,et al.  The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. , 2016, Journal of the American College of Cardiology.

[26]  C. Appleton,et al.  The Incremental Value of Magnetic Resonance Imaging for Identification of Apical Pouch in Patients with Apical Variant of Hypertrophic Cardiomyopathy , 2016, Echocardiography.

[27]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  E. Nagel,et al.  T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. , 2015, Circulation Cardiovascular Imaging.

[29]  Matt A. Bernstein,et al.  Cardiovascular magnetic resonance phase contrast imaging , 2015, Journal of Cardiovascular Magnetic Resonance.

[30]  T. Villines,et al.  Accuracy of cardiac CT, radionucleotide and invasive ventriculography, two- and three-dimensional echocardiography, and SPECT for left and right ventricular ejection fraction compared with cardiac MRI: a meta-analysis. , 2015, European heart journal cardiovascular Imaging.

[31]  N. Smedira,et al.  Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. , 2015, Circulation. Cardiovascular imaging.

[32]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[33]  K. Siminovitch,et al.  Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. , 2014, European heart journal.

[34]  E. Cook,et al.  Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.

[35]  R. Nishimura,et al.  Limitations of Doppler echocardiography in the evaluation of serial stenoses. , 2013, Circulation. Cardiovascular imaging.

[36]  T. Kubo,et al.  Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2013, European heart journal cardiovascular Imaging.

[37]  Andrew S Flett,et al.  Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.

[38]  R. Kwong,et al.  T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular imaging.

[39]  S. K. White,et al.  Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.

[40]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[41]  M. Sherrid,et al.  Role of mitral valve plication in the surgical management of hypertrophic cardiomyopathy. , 2012, The Annals of thoracic surgery.

[42]  Stefan Neubauer,et al.  Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.

[43]  C. Xiao,et al.  Extended myectomy for hypertrophic obstructive cardiomyopathy. , 2012, The heart surgery forum.

[44]  S. Cade,et al.  Exercise Response in Hypertrophic Cardiomyopathy: Blunted Left Ventricular Deformational and Twisting Reserve With Altered Systolic-Diastolic Coupling , 2012, Circulation. Cardiovascular imaging.

[45]  T. Kubo,et al.  Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[46]  R. Kim,et al.  LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. , 2011, JACC. Cardiovascular imaging.

[47]  B. Yashiro,et al.  Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[48]  Vasken Dilsizian,et al.  American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomograph , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[49]  B. Popescu,et al.  Left atrial dysfunction as a correlate of heart failure symptoms in hypertrophic cardiomyopathy. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[50]  Udo Sechtem,et al.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[51]  W. Manning,et al.  Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[52]  F. T. ten Cate,et al.  Delayed left ventricular untwisting in hypertrophic cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[53]  S. Raman,et al.  Influence of Myocardial Fibrosis on Left Ventricular Diastolic Function: Noninvasive Assessment by Cardiac Magnetic Resonance and Echo , 2009, Circulation. Cardiovascular imaging.

[54]  S. Ommen,et al.  The relationship of left atrial volume and left atrial pressure in patients with hypertrophic cardiomyopathy: an echocardiographic and cardiac catheterization study. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[55]  W. Manning,et al.  Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .

[56]  Y. Pinto,et al.  Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. , 2006, Journal of the American College of Cardiology.

[57]  K. Serri,et al.  Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[58]  Stefan Neubauer,et al.  Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[59]  D. Fassbender,et al.  Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. , 2004, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[60]  I. Olivotto,et al.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[61]  M. Sherrid,et al.  Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. , 2003, The Annals of thoracic surgery.

[62]  J. Seidman,et al.  Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. , 1998, The Journal of clinical investigation.

[63]  E. Brockenbrough,et al.  Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. , 1961, Annals of surgery.

[64]  D. Shah,et al.  CMR in the Evaluation of Diastolic Dysfunction and Phenotyping of HFpEF: Current Role and Future Perspectives. , 2019, JACC. Cardiovascular imaging.

[65]  Link,et al.  Genetic basis of hypertrophic cardiomyopathy , 2010 .

[66]  B. Maron,et al.  Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. , 1992, Journal of the American College of Cardiology.